STAT+: PepGen says early trial for muscular dystrophy drug looks promising
PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.
<p>PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.</p>